Properties Gene, mRNA, and precursor Synthesis and release Receptors Biological functions Clinical implications
ChemicalBook > CAS DataBase List > Nesiritide acetate

Nesiritide acetate

Properties Gene, mRNA, and precursor Synthesis and release Receptors Biological functions Clinical implications
Product Name
Nesiritide acetate
CAS No.
114471-18-0
Chemical Name
Nesiritide acetate
Synonyms
BNP-32;Fam-BNP;Nesirtide;BNP HUMAN;BNP-32 (HUMAN);BNP (1-32), HUMAN;NESIRITIDE ACETATE;natriureticpeptide,brain;Nesiritide Acetate (BNP-;Natriuretic factor, brain
CBNumber
CB8676346
Molecular Formula
C143H244N50O42S4
Formula Weight
3464.04
MOL File
114471-18-0.mol
More
Less

Nesiritide acetate Property

storage temp. 
−20°C
solubility 
≥206.6 mg/mL in DMSO
form 
powder
Sequence
H-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His-OH(Disulfide bridge Cys10-Cys26)
CAS DataBase Reference
114471-18-0(CAS DataBase Reference)
More
Less

Safety

WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Usbiological
Product number
153728
Product name
Brain Natriuretic Peptide
Packaging
10ug
Price
$356
Updated
2021/12/16
Usbiological
Product number
153730
Product name
Brain Natriuretic Peptide
Packaging
10ug
Price
$358
Updated
2021/12/16
Usbiological
Product number
153729
Product name
Brain Natriuretic Peptide
Packaging
10ug
Price
$358
Updated
2021/12/16
Usbiological
Product number
153731
Product name
Brain Natriuretic Peptide
Packaging
10ug
Price
$375
Updated
2021/12/16
Usbiological
Product number
B2702-08
Product name
Brain Natriuretic Peptide 32
Packaging
1mg
Price
$382
Updated
2021/12/16
More
Less

Nesiritide acetate Chemical Properties,Usage,Production

Properties

The Mr of mature human BNP is 3466 and the pI is ca. 10. Both pro- and mature BNP are freely soluble in water, acid, and 67% acetone, but insoluble in 99% acetone. BNP solution in water at >10-4M is stable for more than a year at -20°C.

Gene, mRNA, and precursor

The BNP (NPPB) and atrial natriuretic peptide (ANP) genes (NPPA) are thought to be generated by the tandem duplication of the CNP3 gene (NPPC). The human NPPA and NPPB are located on chromosome 1 (1p36.22). The mouse BNP and ANP genes (Nppb and Nppa) are on chromosome 4. NPPB is composed of three exons. Human BNP mRNA is 708 bp (405 bp coding sequence). One of the characteristics of BNP mRNA is a repetitive AUUUA motif in the 30 -untranslated region. The motif is considered to destabilize mRNA, and does not exist in ANP mRNA, suggesting that NPPB is regulated differently from NPPA. Human proBNP is O-glycosylated posttranslationally. O-Glycosylated proBNP is further processed by specific convertases (probably furin and corin) to give rise to the bioactive, mature form of BNP and inactive N-terminal (NT)-proBNP. It is suggested that the cleavage of proBNP is regulated by O-glycosylation at threonine-71.

Synthesis and release

BNP in the cardiac ventricle is secreted via a constitutive pathway as opposed to ANP secretion that occurs via a regulatory pathway (except BNP in the atrium, where BNP is stored and secreted with ANP). BNP production is regulated transcriptionally and various regulatory elements are located in the 50 -flanking region of NPPB, including GATA, M-CAT, and AP-1/CRE-like elements; NRSE; shear stress-responsive elements; thyroid hormone-responsive elements; and the nuclear factor of the activated T-cell (NFAT) binding site. Putative transcription factors are GATA4, YY1, and KLF13.5 BNP expression in cardiomyocytes is enhanced by mechanical stretch, TGF-β, and ET-1.

Receptors

BNP shares two receptors with ANP and VNP (cardiac NP found in ray-finned fish). The A-type NP receptor (NPR-A or GC-A) is a functional receptor, and has a guanylyl cyclase domain that produces cGMP. The order of potency for cGMP production via NPR-A is ANP≥BNP≥CNP in humans. Another receptor is the C-type NP receptor (NPR-C). The NPR-C lacks a cytoplasmic guanylyl cyclase domain, and acts as a clearance receptor. Affinities of NPR-C to NPs are ANP>CNP>BNP in humans. The longer half-life of plasma BNP is attributable mainly to the lower susceptibility to NPR-C. In mammals, NPR-A is highly expressed in the adrenal, brain, kidney, adipose, aortic, and lung tissues, whereas NPR-C is found ubiquitously in most tissues. For more details on NPR-A and NPR-C, the signaling transduction pathway, and the agonists/ antagonists, Atrial natriuretic peptide

Biological functions

The biological actions of BNP are overlapped with those of ANP because they share the same functional receptor, NPR-A . Briefly, BNP induces natriuresis and diuresis by increasing the glomerular filtration rate and decreasing water and sodium reabsorption by the kidney. In addition, BNP decreases aldosterone secretion from the adrenal and vasopressin secretion from the posterior pituitary, which also accelerates natriuresis and diuresis. BNP also decreases systemic vascular resistance by its direct vasorelaxant action. Thus, the net effect of BNP is to decrease blood volume (preload) and systemic blood pressure (afterload), thereby protecting cardiac function. In eels, again similarly to ANP actions, BNP decreases water intake, plasma sodium concentration, and aortic pressure, but the effect is weaker than that of ANP and VNP in the case of eels that have VNP.

Clinical implications

The elevation of plasma BNP concentration is seen in patients with congestive heart failure (CHF), myocardial infarction, hypertension, left ventricular hypertrophy, and chronic renal failure. Although the plasma ANP level is also elevated by such pathological conditions, the increment of the BNP level is quicker and greater than that of ANP. In CHF, for instance, the plasma BNP and ANP concentrations increase 200–300-fold and 10–30-fold, respectively, compared with those in normal humans. The greater increase in BNP level is probably due to its longer half-life in plasma. Thus, the plasma BNP level is used as a reliable biomarker of both ischemic and CHF. NT-proBNP cleaved with the BNP precursor has a longer half-life (about 120min), and thus is used as a more reliable marker for the diagnosis of heart failure. Recent studies showed that a high level of O-glycosylated proBNP circulates in patients with severe heart failure.

Description

B-type natriuretic peptide is the only cardiac natriuretic peptide common to all vertebrate species thus far examined. The plasma BNP level is used as a robust and reliable biomarker for the diagnosis and prognosis of heart failure. BNP was isolated in 1988 from porcine brain extracts and was thus named the brain natriuretic peptide. Soon thereafter, BNP was found to be expressed abundantly in the cardiac ventricle and scarcely in the brains of humans and rats. Currently, BNP has been recognized as a principal cardiac hormone and referred to as the B-type natriuretic peptide.

Uses

hemostatic, antimicrobial

Clinical Use

The severity of CHF assessed by the New York Heart Association (NYHA) functional classification is correlated positively with the elevation of plasma BNP and NT-proBNP levels. Therefore, these peptides are used for the diagnosis and management of patients with CHF. The use of a recombinant BNP, nesiritide, for treatment has been approved by the US Food and Drug Administration. It has beneficial effects in patients with acute, decompensated heart failure; however, it is reported to increase the risk of renal dysfunction and mortality. Further evaluation is required for the clinical use of nesiritide.

Structure and conformation

Human proBNP consists of 108 aa residues with bioactive mature BNP (47 aa residues) at the C-terminus. Like other natriuretic peptides (NPs), BNP has an intramolecular ring consisting of 17 aa residues and N- and C-terminal extensions of varying length. All vertebrate species (tetrapods and fish) except for chondrichthyes and cyclostomes possess BNP.2 Thus, the BNP gene (nppb) is considered to have occurred before the divergence of ray-finned fish and lobefinned fish. The sequence identity of mature BNP is quite variable in mammals (<50% identity between human and mouse BNP), whereas the identity is relatively high among nonmammalian vertebrates.

References

1. Ziskoven D, Forssmann WG, Holthausen U, Menz G, Addicks K, Rippegater G: Calcium Calmodulinantagonists Influences the release of Cardiodilatin/ANP from Atrial Cardiocytes. Handbook Endocrinology of the Heart, edited by Kaufmann W, Wambach G, 01/1989; Springer Verlag Berlin Heidelberg New York;2. Maisel A, Krishnaswamy P, Nowak R, McCord J, Hollander J, Duc P, Omland T, Storrow A, Abraham W, Wu A, Clopton P, Steg P, Westheim A, Knudsen C, Perez A, Kazanegra R, Herrmann H, McCullough P (2002). "Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure". N Engl J Med 347 (3): 161–7.3. O'Connor CM, Starling RC, Hernandez AF, et al. Effect of nesiritide in patients with acute decompensated heart failure. TheNew Englandjournal of medicine 2011;365:32-43.

Nesiritide acetate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Nesiritide acetate Suppliers

Zhongke Huayao (Jiangsu) Biotechnology Co., Ltd
Tel
18014456767 18014456767
Email
wenxi@jszkhy.com
Country
China
ProdList
1350
Advantage
58
Alabiochem Tech.Co., Ltd.
Tel
0512-58900862 400-0707518
Fax
0086-512-56765862
Email
sales@alabiochem.com
Country
China
ProdList
995
Advantage
59
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6005
Advantage
61
GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Fax
86-21-61263399
Email
ymbetter@glbiochem.com
Country
China
ProdList
9981
Advantage
64
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Country
China
ProdList
42958
Advantage
64
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Fax
010-65763397
Email
waley188@sohu.com
Country
China
ProdList
12335
Advantage
58
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-400-6206333 18521732826
Fax
021-50323701
Email
market@aladdin-e.com
Country
China
ProdList
25003
Advantage
65
Guangzhou Isun Pharmaceutical Co., Ltd
Tel
020-39119399 18927568969
Fax
020-39119999
Email
isunpharm@qq.com
Country
China
ProdList
4428
Advantage
55
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
ApexBio Technology LLC
Tel
+1-832-696-8203
Fax
+1-832-641-3177
Email
info@apexbt.com
Country
United States
ProdList
477
Advantage
60
More
Less

View Lastest Price from Nesiritide acetate manufacturers

Hebei Yanxi Chemical Co., Ltd.
Product
Nesiritide acetate 114471-18-0
Price
US $40.00/kg
Min. Order
1kg
Purity
0.99
Supply Ability
10 tons
Release date
2023-09-18
Zibo Hangyu Biotechnology Development Co., Ltd
Product
Nesiritide acetate 114471-18-0
Price
US $80.00-800.00/kg
Min. Order
10kg
Purity
0.99
Supply Ability
20tons
Release date
2023-11-28
Nantong Guangyuan Chemicl Co,Ltd
Product
Nesiritide acetate 114471-18-0
Price
US $10.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
1000kg
Release date
2023-10-13

114471-18-0, Nesiritide acetateRelated Search:


  • natriureticpeptide,brain
  • BRAIN NATRIURETIC PEPTIDE, HUMAN
  • BRAIN NATRIURETIC PEPTIDE (1-32), HUMAN
  • SER-PRO-LYS-MET-VAL-GLN-GLY-SER-GLY-CYS-PHE-GLY-ARG- LYS-MET-ASP-ARG-ILE-SER-SER-SER-SER-GLY-LEU-GLY-CYS-LYS- VAL-LEU-ARG-ARG-HIS(DISULFIDE BRIDGE:CYS10-CYS26)
  • Natriuretic factor, brain
  • Nesirtide
  • Fam-BNP
  • brain natriuretic peptide-32
  • BRAIN NATRIURETIC PEPTIDE-32 (HUMAN)
  • BRAIN(B-TYPE) NATRIURETIC PEPTIDE-32 (HUMAN)
  • B-TYPE (BRAIN) NATRIURETIC PEPTIDE-32 (HUMAN)
  • BNP HUMAN
  • BNP-32; BRAIN NATRIURETIC PEPTIDE-32; ATRIAL NATRIURETIC PEPTIDE; 1-32; HUMAN
  • BNP-32
  • BNP-32 (HUMAN)
  • BNP (1-32), HUMAN
  • H-SER-PRO-LYS-MET-VAL-GLN-GLY-SER-GLY-CYS-PHE-GLY-ARG-LYS-MET-ASP-ARG-ILE-SER-SER-SER-SER-GLY-LEU-GLY-CYS-LYS-VAL-LEU-ARG-ARG-HIS-OH
  • H-SER-PRO-LYS-MET-VAL-GLN-GLY-SER-GLY-CYS-PHE-GLY-ARG-LYS-MET-ASP-ARG-ILE-SER-SER-SER-SER-GLY-LEU-GLY-CYS-LYS-VAL-LEU-ARG-ARG-HIS-OH (DISULFIDE BRIDGE: 10-26)
  • SER-PRO-LYS-MET-VAL-GLN-GLY-SER-GLY-CYS-PHE-GLY-ARG-LYS-MET-ASP-ARG-ILE-SER-SER-SER-SER-GLY-LEU-GLY-CYS-LYS-VAL-LEU-ARG-ARG-HIS
  • SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH (DISULFIDE BRIDGE: 10-26)
  • NESIRITIDE ACETATE
  • Nesiritide Acetate (BNP-32)
  • BRAIN NATRIURETIC PEPTIDE, PORCINE SYNTH ETIC >97%
  • BRAIN NATRIURETIC PEPTIDE
  • atrial natriuretic peptide, 1-32, human
  • Brain natriuretic factor【human】
  • Brain natriuretic factor-32【human】
  • Human brain natriuretic peptide-32
  • SER-PRO-LYS-MET-VAL-GLN-GLY-SER-GLY-CYS-PHE-GLY-ARG-LYS-MET-ASP-ARG-ILE-SER-SER-SER-SER-GLY-LEU-GLY-CYS-LYS-VAL-LEU-ARG-ARG-HIS: SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRHDISULFIDE BRIDGE CYS10-CYS26
  • Nesiritide Acetate (BNP-32) Brain Natriuretic Pept
  • BNP-32 (human) acetate salt
  • Brain natriuretic peptide-32 human, ≥97% (HPLC)
  • Nesiritide Acetate (BNP-
  • Nesiritide acetate USP/EP/BP
  • Nesiritide Acetate (BNP-32)(net)
  • 114471-18-0
  • C143H244N50O42S4
  • Natriuretic Peptides
  • Peptides
  • Amino Acids and Peptides
  • Biochemicals and Reagents
  • BioChemical
  • SignalTransduction
  • Amino Acid Derivatives
  • Peptide